Pennington Biomedical’s 2025 Bray Obesity Symposium to offer on-demand continuing education for physicians

(Press-News.org) FOR IMMEDIATE RELEASE 
April 15, 2025
 

BATON ROUGE – The 2025 Bray Obesity Symposium welcomes all health physicians and researchers interested in the latest in metabolic health to register for the on-demand online offerings. The online-only content is available to access upon registration, and the symposium has been designated by the American Board of Obesity Medicine, or ABOM, as a Group One Primary Medicine Continuing Medical Education partner.

The symposium is an intensive Board Review Course in preparation for the ABOM’s certification exam, including materials from both the 2024 and 2025 exams. The symposium will also feature a variety of topics, including advances in obesity genetics, pediatric obesity, lifestyle intervention, pharmacotherapy, metabolic surgery, and more. The on-demand symposium has been approved for 30 Category 1 Credits for the American Medical Association’s Physician’s Recognition Award, or AMA PRA. To learn more about the symposium and to register, visit the Pennington Biomedical website. 

“The Bray Obesity Symposium provides researchers with the latest insights and guidance from my colleagues at Pennington Biomedical and other obesity centers around the country,” said Dr. Donna Ryan, professor emerita of Pennington Biomedical. “As obesity rates continue to rise, the valuable insights and expertise shared by these researchers will serve as a tremendous asset in medical facilities around the globe.” 

The Bray Obesity Symposium is presented by Pennington Biomedical Research Center, and is named for the center’s founding executive director, Dr. George Bray. He is internationally recognized for his research in obesity in both the basic science and clinical realms, with more than 2,000 publications and an H-Index greater than 120. He is one of the founders and past President of the Obesity Society and the International Association for the Study of Obesity. 

“Dr. Bray is an inspiration to us all, and we are honored to offer this symposium in his name to foster the growth of the next generation of obesity medicine physicians,” said Dr. John Kirwan, Executive Director of Pennington Biomedical. “The symposium was developed by leading faculty members here at Pennington Biomedical, as well as with the assistance colleagues from collaborating institutions. We are proud to structure this symposium so that participants can further their careers with credits and ABOM certification exam preparation.” 

The Bray Obesity Symposium is intended to provide participants with powerful obesity treatment strategies that can be quickly implemented into practice, providing better support for patients with obesity. The learning objectives for the symposium include: 

Demonstrating an understanding of the determinants of obesity, including the role of genetics and epigenetics.  Identifying and evaluating patients with the chronic disease of obesity.  Developing evidence-based obesity management options, including pharmacologic approaches, lifestyle interventions and metabolic surgery as patient-centered approaches for weight loss and improved outcomes in obesity comorbidities.  Applying current multiple individualized treatment modalities to effectively address obesity.  Describing issues in obesity treatment and formulating promotional interventions.  The on-demand continuing education provided by the Bray Obesity Symposium will equip professionals with the insights they need to apply new discoveries and techniques to address the obesity crisis. Register for the Bray Obesity Symposium today.  

About the Pennington Biomedical Research Center
The Pennington Biomedical Research Center is at the forefront of medical discovery as it relates to understanding the triggers of obesity, diabetes, cardiovascular disease, cancer and dementia. Pennington Biomedical has the vision to lead the world in promoting metabolic health and eliminating metabolic disease through scientific discoveries that create solutions from cells to society. The center conducts basic, clinical, and population research, and is a campus in the LSU System.

The research enterprise at Pennington Biomedical includes over 600 employees within a network of 44 clinics and research laboratories, and 13 highly specialized core service facilities. Its scientists and physician/scientists are supported by research trainees, lab technicians, nurses, dietitians, and other support personnel. Pennington Biomedical is a globally recognized state-of-the-art research institution in Baton Rouge, Louisiana.   

 For more information, see www.pbrc.edu.


-30- 


Media Contacts:

Joe Coussan
Pennington Biomedical Research Center
225-763-3049
Joe.coussan@pbrc.edu

Ernie Ballard
Pennington Biomedical Research Center
225-763-2677
Ernie.ballard@pbrc.edu 

END